Citations

Showing 10 of 108094 citations.

Outcomes of patients with autosomal‐dominant polycystic kidney disease on peritoneal dialysis: A meta‐analysis
Boonpheng, Boonphiphop , Thongprayoon, Charat , Wijarnpreecha, Karn , Medaura, Juan , Cheungpasitporn, Wisit , Cheungpasitporn, Wisit , Thongprayoon, Charat , Chebib, Fouad T. , Wijarnpreecha, Karn

Mayo Clinic

Nephrology | June 28, 2018 | Volume: 24 | Issue: 6 | Pages: 638-646

10.1111/nep.13431 | PMID 29952039 Get It

ABSTRACTBackgroundComplications related to peritoneal dialysis (PD) in patients with autosomal‐dominant polycystic kidney disease (ADPKD), including intraperitoneal rupture of renal cyst, hernia, membrane failure and peritonitis, have been reported. However, long‐term clinical outcomes of ADPKD patients on PD remain unclear. We performed this meta‐analysis to assess the risks of death, technique failure and peritonitis in ADPKD patients on PD.MethodsA systematic review was conducted using MEDLINE, EMBASE and Cochrane databases from inception to October 2017 to identify studies that evaluated the outcomes of ADPKD patients on PD, including the risks of death, technique failure and peritonitis. Non‐ADPKD patients on PD were used as controls. Effect estimates from the individual study were extracted and combined using the random‐effect, generic inverse variance method of DerSimonian and Laird.ResultsTwelve cohort studies with a total of 14 673 patients on PD (931 ADPKD and 13 742 non‐ADPKD patients) were enrolled. Compared with non‐ADPKD status, ADPKD was associated with significantly decreased mortality risk with pooled odds ratio (OR) of 0.68 (95% confidence interval (CI), 0.53–0.86; I2 = 0). There were no associations of ADPKD with the risks of technique failure of PD and peritonitis with pooled OR of 0.93 (95% CI, 0.79–1.10; I2 = 0) and 0.88 (95% CI, 0.75–1.05; I2 = 0), respectively. We found no publication bias as assessed by Egger's regression asymmetry test, with P = 0.90, 0.28 and 0.60 for the risks of mortality, technique failure and peritonitis in ADPKD patients on PD, respectively.ConclusionCompared with non‐ADPKD patients on PD, our study demonstrates that ADPKD patients on PD have 0.68‐fold decreased mortality risk. There are no associations of ADPKD status with the risks of technique failure or peritonitis.
Cigarette smoking and risk of celiac disease: A systematic review and meta‐analysis
Wijarnpreecha, Karn , Lou, Susan , Panjawatanan, Panadeekarn , Cheungpasitporn, Wisit , Pungpapong, Surakit , Lukens, Frank , Ungprasert, Patompong , Lukens, Frank J., Cheungpasitporn, Wisit , Pungpapong, Surakit , Wijarnpreecha, Karn

Mayo Clinic

United European Gastroenterology Journal | June 28, 2018 | Volume: 6 | Issue: 9 | Pages: 1285-1293

10.1177/2050640618786790 | PMID 30386601 Get It

Background/ObjectivesA negative association between cigarette smoking and celiac disease has been observed but results were inconsistent across the published studies. A meta‐analysis was conducted with the aim to identify all studies that investigated this association and to summarize the results of those studies.MethodsA comprehensive literature review was conducted utilizing MEDLINE and Embase databases through March 2018 to identify all cohort studies and case‐control studies that compared the risk of celiac disease among current and/or former smokers versus never‐smokers. Effect estimates from each study were extracted and combined together using the random‐effect, generic inverse variance method of DerSimonian and Laird.ResultsA total of seven studies with 307,924 participants fulfilled the eligibility criteria and were included in the meta‐analysis. The pooled analysis found a significantly decreased risk of celiac disease among current smokers compared with never‐smokers with the pooled odds ratio (OR) of 0.52 (95% confidence interval (CI), 0.32–0.84; I2 86%). However, the risk of celiac disease among former smokers was not significantly different from never‐smokers with the pooled OR of 1.10 (95% CI, 0.76–1.60; I2 of 73%).ConclusionsA significantly decreased risk of celiac disease among current smokers compared with never‐smokers was demonstrated in this meta‐analysis.
Outcomes Associated With Apixaban Use in Patients With End-Stage Kidney Disease and Atrial Fibrillation in the United States
Siontis, Konstantinos C. , Zhang, Xiaosong , Eckard, Ashley, Bhave, Nicole M. , Schaubel, Douglas E. , Tilea, Anca , Stack, Austin G. , Shah, Nilay D. , Saran, Rajiv , Nallamothu, Brahmajee K. , Yao, Xiaoxi , He, Kevin , Balkrishnan, Rajesh , Noseworthy, Peter A.

Mayo Clinic

Circulation | June 28, 2018 | Volume: 138 | Issue: 15 | Pages: 1519-1529

10.1161/circulationaha.118.035418 | PMID 29954737 Get It

Background: Patients with end-stage kidney disease (ESKD) on dialysis were excluded from clinical trials of direct oral anticoagulants for atrial fibrillation (AF). Recent data have raised concerns regarding the safety of dabigatran and rivaroxaban, but apixaban has not been evaluated despite current labeling supporting its use in this population. The goal of this study was to determine patterns of apixaban use and its associated outcomes in dialysis-dependent patients with ESKD and AF. Methods: We performed a retrospective cohort study of Medicare beneficiaries included in the United States Renal Data System (October 2010 to December 2015). Eligible patients were those with ESKD and AF undergoing dialysis who initiated treatment with an oral anticoagulant. Because of the small number of dabigatran and rivaroxaban users, outcomes were only assessed in patients treated with apixaban or warfarin. Apixaban and warfarin patients were matched (1:3) based on prognostic score. Differences between groups in survival free of stroke or systemic embolism, major bleeding, gastrointestinal bleeding, intracranial bleeding, and death were assessed using Kaplan–Meier analyses. Hazard ratios (HRs) and 95% CIs were derived from Cox regression analyses. Results: The study population consisted of 25 523 patients (45.7% women; 68.2±11.9 years of age), including 2351 patients on apixaban and 23 172 patients on warfarin. An annual increase in apixaban prescriptions was observed after its marketing approval at the end of 2012, such that 26.6% of new anticoagulant prescriptions in 2015 were for apixaban. In matched cohorts, there was no difference in the risks of stroke/systemic embolism between apixaban and warfarin (HR, 0.88; 95% CI, 0.69–1.12; P =0.29), but apixaban was associated with a significantly lower risk of major bleeding (HR, 0.72; 95% CI, 0.59–0.87; P <0.001). In sensitivity analyses, standard-dose apixaban (5 mg twice a day; n=1034) was associated with significantly lower risks of stroke/systemic embolism and death as compared with either reduced-dose apixaban (2.5 mg twice a day; n=1317; HR, 0.61; 95% CI, 0.37–0.98; P =0.04 for stroke/systemic embolism; HR, 0.64; 95% CI, 0.45–0.92; P =0.01 for death) or warfarin (HR, 0.64; 95% CI, 0.42–0.97; P =0.04 for stroke/systemic embolism; HR, 0.63; 95% CI, 0.46–0.85; P =0.003 for death). Conclusions: Among patients with ESKD and AF on dialysis, apixaban use may be associated with a lower risk of major bleeding compared with warfarin, with a standard 5 mg twice a day dose also associated with reductions in thromboembolic and mortality risk.
Retrospective Evaluation of the Safety of Large Skin Flap, Large Skin Graft, and Interpolation Flap Surgery in the Outpatient Setting
Schmitt, Adam R., DePry, Jennifer L., Tsai, Sheena, Bordeaux, Jeremy S. , Schmitt, Adam

Mayo Clinic

Dermatologic Surgery | June 27, 2018 | Volume: 44 | Issue: 12 | Pages: 1537-1546

10.1097/dss.0000000000001605 | PMID 29957663 Get It

BACKGROUND As the number of cutaneous surgeries continues to increase, it is important to evaluate the safety of dermatologic surgery in the outpatient setting. OBJECTIVE The authors sought to determine postoperative bleeding, infection, dehiscence, and necrosis rates in office-based dermatologic surgery using large flap, large graft, and interpolation flap repairs. The authors evaluated the relationship between these complications and surgical site, closure type, repair size, antibiotic use, and antithrombotic use. METHODS Eligible patients were identified through searching the electronic medical records from one Mohs micrographic surgeon at University Hospitals Medical Center. Patient information, surgery characteristics, and complication information were collected. Univariate and multivariate analyses were conducted to reveal associations between each complication and closure type, repair size, repair site, antithrombotic use, and antibiotic use. RESULTS Three hundred and thirty-one reconstruction procedures after Mohs micrographic surgery and excision qualified for the study. The rates of postoperative infection, hemorrhage, hematoma, necrosis, and dehiscence were 5%, 0.3%, 2.4%, 3%, and 0.9%, respectively. CONCLUSION Complications were infrequent and non–life-threatening. The authors' results indicate that dermatologic surgery using large flaps, interpolation flaps, and large grafts is safe in the office setting.
Strengthening the Case for the Role of Thrombophilia in Calciphylaxis
Hickson, LaTonya J. , McBane, Robert D. , El-Azhary, Rokea A, Hickson, LaTonya J , el‐Azhary, Rokea A.

Mayo Clinic

JAMA Dermatology | June 27, 2018 | Volume: 154 | Issue: 8 | Pages: 970

10.1001/jamadermatol.2018.1535 | PMID 29955772 Get It

Clinical PET/MRI: 2018 Update
Goenka, Ajit H. , Kemp, Bradley J. , Johnson, Geoffrey B. , Johnson, Geoffrey B , Broski, Stephen M.

Mayo Clinic

American Journal of Roentgenology | June 27, 2018 | Volume: 211 | Issue: 2 | Pages: 295-313

10.2214/ajr.18.20001 | PMID 29949413 Get It

Faculty Opinions recommendation of Dilation or biodegradable stent placement for recurrent benign esophageal strictures: a randomized controlled trial.
Song, Louis M. Wong Kee

Mayo Clinic

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature | June 27, 2018 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.3410/f.733422136.793547518 Get It

Distributed ledgers in transfusion medicine: an opportunity for standards to accelerate innovation
Gniadek, Thomas J. , Ball, Peter A.

Mayo Clinic

Transfusion | June 27, 2018 | Volume: 58 | Issue: 6 | Pages: 1567-1567

10.1111/trf.14576 | PMID 29949193 Get It

Healed Fracture of Superior Horn of Thyroid Cartilage in Autoerotic Asphyxia: An Indication of Prior Activity? A Case Report Utilizing 3D Scanning and Printing of the Larynx
Eckhardt, Michael, Shah, Kabeer , Bois, Melanie C. , Maleszewski, Joseph J. , Moore, Kellyanna, Lin, Peter T. , Bois, Melanie, Maleszewski, Joseph, Lin, Peter , Eckhardt, Michael D.

Mayo Clinic

Academic Forensic Pathology | June 27, 2018 | Volume: 8 | Issue: 1 | Pages: 170-179

10.23907/2018.012 | PMID 31240033 Get It

Evidence of prior autoerotic asphyxia is often difficult to establish due to the decedent's efforts to hide the activity from others. In this case report, we suggest that a healed fracture of the thyroid cartilage is indicative of prior autoerotic asphyxia activity. The decedent was a 45-year-old man who was found unclothed on the floor of his bedroom with a belt ligature around the neck. A second rope ligature was loosely wrapped around the decedent's wrists, scrotum, and penis. A definitive escape mechanism was not identified, but a nearby towel and barbell weight may have comprised a possible escape mechanism. There was no known history of depression or prior autoerotic activity. Autopsy was notable for the presence of a healed fracture of the right superior horn of the thyroid cartilage. Three-dimensional (3D) surface scanning and 3D printing was utilized to preserve the anatomical findings prior to histologic sampling. To our knowledge, this is the first reported use of 3D surface scanning and 3D printing for the purpose of documenting a forensic finding prior to alteration of the anatomical specimen for histologic sampling. Acute fractures of the superior horns of the thyroid cartilage are not infrequently seen in ligature hanging. Therefore, the presence of a healed fracture in the setting of autoerotic asphyxia likely indicates prior activity. Histologic sampling of the laryngeal cartilages to detect occult healed fractures in autoerotic asphyxia may be useful. Three-dimensional scanning and printing may alleviate concerns for specimen alteration due to histology sampling.
National Association of Medical Examiners Position Paper: Retaining Postmortem Samples for Genetic Testing
Middleton, Owen, Baxter, Samantha, Demo, Erin, Honeywell, Christina, Jentzen, Jeff, Miller, Frank P., Pinckard, J. Keith, Reichard, R. Ross , Rutberg, Julie, Stacy, C Christopher, MacLeod, Heather , Jentzen, Jeffrey M.

Mayo Clinic

Academic Forensic Pathology | June 27, 2018 | Volume: 3 | Issue: 2 | Pages: 191-194

10.23907/2013.024 Get It

Sudden unexpected death is typically diagnosed in infants, children, teenagers, and young adults following completion of an autopsy that fails to identify a cause of death or when autopsy suggests a potentially genetic cause of death in an individual less than 40, such as cardiomyopathy or aneurysm. Such deaths may be a result of genetic abnormalities that are unable to be diagnosed by gross or microscopic inspection, but may be detectable by molecular studies. Unfortunately, the ability to perform postmortem genetic testing is frequently hindered by lack of an appropriate specimen following completion of an autopsy. This paper provides recommendations developed by the National Association of Medical Examiners with the assistance of genetic counselors. The recommendations establish procedures to facilitate postmortem genetic testing and DNA banking by health care professionals assisting families who have experienced sudden death in young relatives by clarifying proper sample acquisition and storage. Additionally, recommendations for discussion with surviving family members and test planning are provided. The objective of these recommendations is to ensure that postmortem samples suitable for DNA banking are retained, allowing at risk family members improved detection of potentially treatable genetic diseases.